The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region

Journal of Virology

Volumn 85, Issue 21, 2011, Pages 10968-10975

  Krawczyk, Ewa ^a   Suprynowicz, Frank A ^a   Hebert, Jess D ^a   Kamonjoh, Christopher M ^a   Schlegel, Richard ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 2; PROTEIN E5; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MEMBRANE FUSION; MEMBRANE VESICLE; NONHUMAN; PERINUCLEAR REGION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TRANSPORT;

ANIMALS; ANNEXIN A2; CELL LINE; CERCOPITHECUS AETHIOPS; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOPRECIPITATION; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; PROTEIN INTERACTION MAPPING;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 80055120146     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00706-11     Document Type: Article

References (58)

1. Ashrafi, G. H., M. Haghshenas, B. Marchetti, and M. S. Campo. 2006. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int. J. Cancer 119: 2105-2112.
2. Baege, A. C., A. Berger, R. Schlegel, T. Veldman, and R. Schlegel. 2002. Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. Am. J. Pathol. 160:1251-1257.
3. Bodily, J., and L. A. Laimins. 2011. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol. 19:33-39.
4. Chen, S. L., S. T. Lin, T. C. Tsai, W. C. Hsiao, and Y. P. Tsao. 2006. ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein. Oncogene 26:42-53.
5. Chinnapen, D. J., H. Chinnapen, D. Saslowsky, and W. I. Lencer. 2007. Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. FEMS Microbiol. Lett. 266:129-137.
6. Conrad, M., V. J. Bubb, and R. Schlegel. 1993. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67:6170-6178.
7. Disbrow, G. L., I. Sunitha, C. C. Baker, J. Hanover, and R. Schlegel. 2003. Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology 311:105-114.
8. Doorbar, J. 2005. The papillomavirus life cycle. J. Clin. Virol. 32S:7-15.
9. Emans, N., et al. 1993. Annexin II is a major component of fusogenic endosomal vesicles. J. Cell Biol. 120:1357-1369.
10. Erikson, E., H. G. Tomasiewicz, and R. L. Erikson. 1984. Biochemical characterization of a 34-kilodalton normal cellular substrate of pp60v-src and an associated 6-kilodalton protein. Mol. Cell. Biol. 4:77-85.
11. Fehrmann, F., and L. A. Laimins. 2003. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 22: 5201-5207.
12. Filipenko, N. R., and D. M. Waisman. 2001. The C terminus of annexin II mediates binding to F-actin. J. Biol. Chem. 276:5310-5315.
13. Futter, C. E., and I. J. White. 2007. Annexins and endocytosis. Traffic 8:951-958.
14. Genther Williams, S. M., et al. 2005. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res. 65:6534-6542.
15. 2+ signaling to membrane dynamics. Nat. Rev. Mol. Cell. Biol. 6:449-461.
16. Gerke, V., and S. E. Moss. 2002. Annexins: from structure to function. Physiol. Rev. 82:331-371.
17. Gerke, V., and K. Weber. 1984. Identity of p36K phosphorylated upon Rous sarcoma virus transformation with a protein purified from brush borders; calcium-dependent binding to non-erythroid spectrin and F-actin. EMBO J. 3:227-233.
18. Gerke, V., and K. Weber. 1985. Calcium-dependent conformational changes in the 36-kDa subunit of intestinal protein I related to the cellular 36-kDa target of Rous sarcoma virus tyrosine kinase. J. Biol. Chem. 260:1688-1695.
19. Glenney, J. R., Jr., and B. F. Tack. 1985. Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100. Proc. Natl. Acad. Sci. U. S. A. 82:7884-7888.
20. Gruener, M., I. G. Bravo, F. Momburg, A. Alonso, and P. Tomakidi. 2007. The E5 protein of the human papillomavirus type 16 downregulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells. Virol. J. 4:116-130.
21. Hajdu, S. I. 2006. A note from history: the link between koilocytes and human papillomaviruses. Ann. Clin. Lab. Sci. 36:485-487.
22. Hayes, M. J., D. Shao, M. Bailly, and S. E. Moss. 2006. Regulation of actin dynamics by annexin 2. EMBO J. 25:1816-1826.
23. Heyraud, S., et al. 2008. Contribution of annexin 2 to the architecture of mature endothelial adherens junctions. Mol. Cell. Biol. 28:1657-1668.
24. Johnsson, N., G. Marriott, and K. Weber. 1988. p36, the major cytoplasmic substrate of src tyrosine protein kinase, binds to its p11 regulatory subunit via a short amino-terminal amphiphatic helix. EMBO J. 7:2435-2442.
25. Johnstone, S. A., I. Hubaishy, and D. M. Waisman. 1992. Phosphorylation of annexin II tetramer by protein kinase C inhibits aggregation of lipid vesicles by the protein. J. Biol. Chem. 267:25976-25981.
26. Klein, O., et al. 1998. Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor beta receptor activation and cell transformation. J. Virol. 72:8921-8932.
27. Krawczyk, E., J. A. Hanover, R. Schlegel, and F. A. Suprynowicz. 2008. Karyopherin β3: a new cellular target for the HPV-16 E5 oncoprotein. Biochem. Biophys. Res. Commun. 371:684-688.
28. Krawczyk, E., et al. 2008. Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am. J. Pathol. 173:682-688.
29. Krawczyk, E., F. A. Suprynowicz, S. R. Sudarshan, and R. Schlegel. 2010. Membrane orientation of the human papillomavirus type 16 E5 oncoprotein. J. Virol. 84:1696-1703.
30. Lazarczyk, M., et al. 2008. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med. 205:35-42.
31. Lim, P. S., et al. 1990. Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. J. Infect. Dis. 162:1263-1269.
32. Mayorga, L. S., et al. 1994. Calcium-dependent fusion among endosomes. J. Biol. Chem. 269:30927-30934.
33. Mayran, N., R. G. Parton, and J. Gruenberg. 2003. Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J. 22:3242-3253.
34. Moody, C. A., and L. A. Laimins. 2010. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 10:550-560.
35. Morel, E., and J. Gruenberg. 2007. The p11/S100A10 light chain of annexin A2 is dispensable for annexin A2 association to endosomes and functions in endosomal transport. PLoS One 2:e1118.
36. Morel, E., R. G. Parton, and J. Gruenberg. 2009. Annexin A2-dependent polymerization of actin mediates endosome biogenesis. Dev. Cell 16:445-457.
37. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
38. Orth, G. 2008. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr. Top. Microbiol. Immunol. 321:59-83.
39. Parton, R. G. 1994. Ultrastructural localization of gangliosides: GM1 is concentrated in caveolae. J. Histochem. Cytochem. 42:155-166.
40. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U. S. A. 90:8392-8396.
41. Puisieux, A., J. Ji, and M. Ozturk. 1996. Annexin II upregulates cellular levels of p11 protein by a post-translational mechanism. Biochem. J. 313:51-55.
42. Raynor, C. M., J. F. Wright, D. M. Waisman, and E. L. Pryzdial. 1999. Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes. Biochemistry 38:5089-5095.
43. Regan, J. A., and L. A. Laimins. 2008. Bap31 is a novel target of the human papillomavirus E5 protein. J. Virol. 82:10042-10051.
44. Rescher, U., and V. Gerke. 2004. Annexins: unique membrane binding proteins with diverse functions. J. Cell Sci. 117:2631-2639.
45. +-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene 19:3727-3732.
46. Schlegel, R., W. C. Phelps, Y. L. Zhang, and M. Barbosa. 1988. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J. 7:3181-3187.
47. Sparkowski, J., J. Anders, and R. Schlegel. 1994. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. J. Virol. 68:6120-6123.
48. Suprynowicz, F. A., G. L. Disbrow, V. Simic, and R. Schlegel. 2005. Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? Virology 332:102-113.
49. Suprynowicz, F. A., et al. 2008. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. Oncogene 27:1071-1078.
50. Suprynowicz, F. A., et al. 2010. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. J. Virol. 84:10619-10629.
51. 2+-binding sites. J. Cell Sci. 103:733-742.
52. Trojanowski, J. Q., J. O. Gonatas, and N. K. Gonatas. 1982. Horseradish peroxidase (HRP) conjugates of cholera toxin and lectins are more sensitive retrogradely transported markers than free HRP. Brain Res. 231:33-50.
53. Waisman, D. M. 1995. Annexin II tetramer: structure and function. Mol. Cell. Biochem. 149-. 150:301-322.
54. Wang, P., N. R. Chintagari, D. Gou, L. Su, and L. Liu. 2007. Physical and functional interactions of SNAP-23 with annexin A2. Am. J. Respir. Cell Mol. Biol. 37:467-476.
55. Yamamoto, L. S., et al. 2004. A morphological protocol and guide-list on uterine cervix cytology associated to papillomavirus infection. Rev. Inst. Med. Trop. Sao Paulo 46:189-193.
56. Zobiack, N., U. Rescher, C. Ludwig, D. Zeuschner, and V. Gerke. 2003. The annexin 2/S100A10 complex controls the distribution of transferrin receptorcontaining recycling endosomes. Mol. Biol. Cell 14:4896-4908.
57. Zokas, L., and J. R. Glenney. 1987. The calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: studies using monoclonal antibodies to calpactin subunits. J. Cell Biol. 105:2111-2121.
58. Zur Hausen, H. 2009. Papillomaviruses in the causation of human cancers: a brief historical account. Virology 384:260-265.